Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;68(2):414-8.
doi: 10.1093/jac/dks409. Epub 2012 Oct 19.

Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance

Affiliations

Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance

Farbod Babrzadeh et al. J Antimicrob Chemother. 2013 Feb.

Abstract

Objectives: To determine whether pan-protease inhibitor (PI)-resistant virus populations are composed predominantly of viruses with resistance to all PIs or of diverse virus populations with resistance to different subsets of PIs.

Methods: We performed deep sequencing of plasma virus samples from nine patients with high-level genotypic and/or phenotypic resistance to all licensed PIs. The nine virus samples had a median of 12 PI resistance mutations by direct PCR Sanger sequencing.

Results: For each of the nine virus samples, deep sequencing showed that each of the individual viruses within a sample contained nearly all of the mutations detected by Sanger sequencing. Indeed, a median of 94.9% of deep sequence reads had each of the PI resistance mutations present as a single chromatographic peak in the Sanger sequence. A median of 5.0% of reads had all but one of the Sanger mutations that were not part of an electrophoretic mixture.

Conclusions: The collinearity of PI resistance mutations in the nine virus samples demonstrated that pan-PI-resistant viruses are able to replicate in vivo despite their highly mutated protease enzymes. We hypothesize that the marked collinearity of PI resistance mutations in pan-PI-resistant virus populations results from the unique requirements for multi-PI resistance and the extensive cross-resistance conferred by many of the accessory PI resistance mutations.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Talbot A, Grant P, Taylor J, et al. Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitors. Antimicrob Agents Chemother. 2010;54:2473–9. doi:10.1128/AAC.00096-10. - DOI - PMC - PubMed
    1. Doherty KM, Nakka P, King BM, et al. A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes. BMC Bioinformatics. 2011;12:477. doi:10.1186/1471-2105-12-477. - DOI - PMC - PubMed
    1. Weinheimer S, Discotto L, Friborg J, et al. Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbones. Antimicrob Agents Chemother. 2005;49:3816–24. doi:10.1128/AAC.49.9.3816-3824.2005. - DOI - PMC - PubMed
    1. Wiesmann F, Vachta J, Ehret R, et al. The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors atazanavir and saquinavir: is there a clinical advantage? AIDS Res Ther. 2011;8:7. doi:10.1186/1742-6405-8-7. - DOI - PMC - PubMed
    1. Ziermann R, Limoli K, Das K, et al. A mutation in human immunodeficiency virus type 1 protease, N88S, that causes in vitro hypersensitivity to amprenavir. J Virol. 2000;74:4414–9. doi:10.1128/JVI.74.9.4414-4419.2000. - DOI - PMC - PubMed

Publication types